(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 18136.80 | 17383.50 | 4.33 | 18136.80 | 17383.50 | 4.33 | 69290.50 | 64091.50 | 8.11 |
| Other Income | 753.70 | 728.40 | 3.47 | 753.70 | 728.40 | 3.47 | 2881.40 | 2755.80 | 4.56 |
| PBIDT | 5978.70 | 5184.30 | 15.32 | 5978.70 | 5184.30 | 15.32 | 21802.20 | 19701.80 | 10.66 |
| Interest | 59.10 | 58.20 | 1.55 | 59.10 | 58.20 | 1.55 | 249.90 | 114.30 | 118.64 |
| PBDT | 5919.60 | 5126.10 | 15.48 | 5919.60 | 5126.10 | 15.48 | 21552.30 | 19587.50 | 10.03 |
| Depreciation | 197.50 | 194.80 | 1.39 | 197.50 | 194.80 | 1.39 | 759.60 | 718.00 | 5.79 |
| PBT | 5722.10 | 4931.30 | 16.04 | 5722.10 | 4931.30 | 16.04 | 20792.70 | 18869.50 | 10.19 |
| TAX | 1436.90 | 1272.70 | 12.90 | 1436.90 | 1272.70 | 12.90 | 5272.50 | 4725.10 | 11.58 |
| Deferred Tax | -31.80 | -5.00 | 536.00 | -31.80 | -5.00 | 536.00 | -107.20 | 27.20 | -494.12 |
| PAT | 4285.20 | 3658.60 | 17.13 | 4285.20 | 3658.60 | 17.13 | 15520.20 | 14144.40 | 9.73 |
| Equity | 212.50 | 212.50 | 0.00 | 212.50 | 212.50 | 0.00 | 212.50 | 212.50 | 0.00 |
| PBIDTM(%) | 32.96 | 29.82 | 10.53 | 32.96 | 29.82 | 10.53 | 31.46 | 30.74 | 2.36 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1924.90 |
| Dr. Reddys Labs. | 1202.00 |
| Cipla | 1450.00 |
| Lupin | 2235.00 |
| Zydus Lifesciences | 1140.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: